首页> 外文学位 >Metal-Chelating Polymers for Auger Electron Radioimmunotherapy.
【24h】

Metal-Chelating Polymers for Auger Electron Radioimmunotherapy.

机译:用于俄歇电子放射免疫疗法的金属螯合聚合物。

获取原文
获取原文并翻译 | 示例

摘要

Radioimmunotherapy is a promising strategy for cancer treatment. The incorporation of metal-chelating polymers (MCPs) into radioimmunoconjugates (RICs) can increase the specific activities of RICs due to the multiple radioactive isotope binding sites provided by MCPs. This thesis describes the synthesis and characterization of a library of biotin end-capped MCPs (Bi-MCP). These Bi-MCP are designed to conjugate with the Fab fragment of trastuzumab modified with streptavidin (tmFab-SAv) and labeled with 111In, to form RICs. Trastuzumab has specific targeting ability towards human epidermal growth factor receptor-2 (HER2), which is overexpressed on certain types of breast cancer cells. 111In can generate Auger electrons which are able to induce the lethal cleavage of nuclear DNA. The strategy of labeling tmFab-SAv with Bi-MCP should enhance the number of 111In delivered per HER2 targeting event, and thereby increase the radiotoxicity delivered to the HER2+ cancer cells.;Auger electrons have ultrashort tissue penetration ranges (< 1 microm). Therefore, to exert their effects, the RICs have to internalize into the cells and reach close proximity to the nucleus. In an attempt to enhance the nuclear uptake of the tmFab-SAv-Bi-MCP, I chemically incorporated Doxorubicin (Dox) into the Bi-MCP as a nuclear targeting moiety and compared this RIC with a similar Bi-MCP-RIC without Dox. A series of in vitro experiments were carried out to evaluate the immunoreactivity and subcellular localization of these MCP-containing RICs. The results showed that upon complexation of the MCPs, HER2-targeting ability of tmFab was retained, ensuring the cell-selectivity of these RICs. The Dox did not increase nuclear uptake, whereas the Bi-MCP itself appeared to encourage internalization, nuclear uptake and chromatin (DNA) binding of tmFab-SAv-Bi-MCP.;Biodistribution profiles of the RICs containing MCPs were screened in a Balb/c mouse model. The MCPs bearing negative charges along the polymer backbone caused the ultrafast clearance of the tmFab-SAv from blood circulation via the hepatic route. On the contrary, Bi-MCPs bearing zwitterionic pendant groups upon complexation with indium ions, showed substantially reduced liver uptake of the tmFab-SAv complex and a longer plasma half-life.
机译:放射免疫疗法是一种有前途的癌症治疗策略。由于MCP提供的多个放射性同位素结合位点,将金属螯合聚合物(MCP)掺入放射免疫偶联物(RIC)中可以提高RIC的比活性。本文描述了生物素封端的MCP(Bi-MCP)库的合成和表征。设计这些Bi-MCP与经链霉亲和素(tmFab-SAv)修饰并用111 In标记的曲妥珠单抗的Fab片段缀合,以形成RIC。曲妥珠单抗具有针对人表皮生长因子受体2(HER2)的特异性靶向能力,该因子在某些类型的乳腺癌细胞中过表达。 111In可产生俄歇电子,该俄歇电子能够诱导核DNA的致死裂解。用Bi-MCP标记tmFab-SAv的策略应增加每个HER2靶向事件传递的111 In数量,从而增加传递给HER2 +癌细胞的放射毒性。俄歇电子具有超短的组织穿透范围(<1微米)。因此,为了发挥作用,RIC必须内化到细胞中并紧密靠近细胞核。为了增强tmFab-SAv-Bi-MCP的核吸收,我将阿霉素(Dox)化学掺入Bi-MCP中作为核靶向部分,并将该RIC与没有Dox的类似Bi-MCP-RIC进行了比较。进行了一系列体外实验,以评估这些含MCP的RIC的免疫反应性和亚细胞定位。结果表明,在MCP络合后,保留了tmFab的HER2靶向能力,从而确保了这些RIC的细胞选择性。 Dox并没有增加核吸收,而Bi-MCP本身似乎鼓励tmFab-SAv-Bi-MCP的内在化,核吸收和染色质(DNA)结合。在Balb /中筛选了含MCP的RIC的生物分布图c鼠标模型。沿着聚合物主链带有负电荷的MCP导致tmFab-SAv通过肝途径从血液循环中超快清除。相反,在与铟离子络合后带有两性离子侧基的Bi-MCPs显着降低了tmFab-SAv络合物的肝脏吸收,并具有更长的血浆半衰期。

著录项

  • 作者

    Liu, Peng.;

  • 作者单位

    University of Toronto (Canada).;

  • 授予单位 University of Toronto (Canada).;
  • 学科 Polymer chemistry.;Medical imaging.;Pharmaceutical sciences.
  • 学位 Ph.D.
  • 年度 2015
  • 页码 209 p.
  • 总页数 209
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号